Sign in

Danny Gale

@dannygale.bsky.social
920 followers 825 following 5 posts

Nephrologist @RoyalFreeNHS and rare disease researcher @UCL using genomics to understand kidney disease. @RenalRaDaR director. www.ucl.ac.uk/medicine/research/gen…

PostsRepliesMedia
Danny Gale @dannygale.bsky.social · 15/04/2026
Have you ever wondered which is a better predictor of long-term outcomes in people with rare kidney diseases, urine protein:creatinine ratio or urine albumin:creatinine ratio? We looked in the RaDaR dataset to find out: doi.org/10.1093/ndt/...
doi.org
Association of UACR and UPCR with kidney failure: analysis of observational data in patients with rare kidney diseases
AbstractBackground. Proteinuria is associated with long-term kidney failure (KF) risk. In trials of CKD and diabetic kidney disease, urine albumin: creatin
020
Danny Gale @dannygale.bsky.social · 04/12/2025
Very pleased to see this RCT of Pegcetacoplan in #C3G and primary #ICMPGN published because it shows evidence of a transformational effect of this treatment in people with a #RareDisease. www.nejm.org/doi/full/10....
nejm.org
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN | NEJM
C3 glomerulopathy and primary immune-complex membranoproliferative glomerulonephritis (MPGN) generally result in glomerular C3 deposition and irreversible kidney damage. The efficacy and safety of ...
030
Reposted by Danny Gale
UK Kidney Association @ukkidney.org · 24/11/2025
Now online in @ndt-era.bsky.social – this article by Prof Daniel Gale shows how RaDaR data are accelerating drug development for rare kidney diseases – informing NICE appraisals, regulatory endpoints & clinical trials for IgA nephropathy, FSGS, C3G & Alport syndrome. 📄: ow.ly/L9HK50XqqqT
033
Reposted by Danny Gale
ASN Publications @asnpublications.bsky.social · 25/11/2025
In this new perspective article in #ASNJASN, authors detail a national system of iteration enabling bidirectional flow between clinical care and whole genome sequencing. Read more: kidney.pub/JASN0922 @dannygale.bsky.social
022
Reposted by Danny Gale
Daniel MacArthur @dgmacarthur.bsky.social · 14/10/2025
Awesome work by @zornitza.bsky.social and collaborators showing the immediate value of WGS for newborn screening in a cohort of 1,000 Australian babies. Now we need larger, more diverse cohorts to show this approach can achieve population scale!
0136
Danny Gale @dannygale.bsky.social · 02/10/2025
If you’re interested in learning about all things genetic in nephrology, come to our Renal Genomics course in London, 5-6 March 2026!
021
Reposted by Danny Gale
Michael Walsh @lastwalsh.bsky.social · 12/08/2025
Int Society of Nephrology Glomerular Disease fellowships! Our program is not on the small ISN list but can host ISN fellows. We offer glomerular disease clinics, vasculitis clinics, genetics clinics, onconeph clinics and research opportunities. DM if interested! www.theisn.org/in-action/gr...
theisn.org
Fellowships - International Society of Nephrology
%
044
Reposted by Danny Gale
Jeff Miner @jeffminerphd.bsky.social · 31/07/2025
Thrilled to have this finally published! If you are interested in learning about the collagen IV diseases Gould syndrome and Alport syndrome, add this to your reading list. www.nature.com/articles/s41...
nature.com
Collagen IV in Gould syndrome and Alport syndrome
Nature Reviews Nephrology - In this Review, the authors focus on the role of collagen IV in Gould syndrome and Alport syndrome. They discuss the molecular and phenotypic similarities and...
53110
Reposted by Danny Gale
Nephrology Times @nephtimes.bsky.social · 30/07/2025
⚠️ The FDA has approved pegcetacoplan (Empaveli) for treating C3G and IC-MPGN. #kidneydisease #nephrology #nephsky #c3g www.docwirenews.com/post/fda-app...
docwirenews.com
FDA Approves Pegcetacoplan for C3G and IC-MPGN | Docwire News
The FDA approved pegcetacoplan for treating C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN in patients age 12 and older.
096
Reposted by Danny Gale
Neil Turner @neilturn.bsky.social · 30/05/2025
The Alport Workshop in Beijing in September is looking tremendous! Agenda to be added soon, but register now at tinyurl.com/5674vckz @alportuk.bsky.social @dannygale.bsky.social @rheaultm.bsky.social @rachellennon.bsky.social‬
053
Reposted by Danny Gale
@vasculitides @vasculitides.bsky.social · 11/04/2025
Proteinuria Trajectory and Disease Progression in Children and Adults with IgA Nephropathy/Vasculitis pubmed.ncbi.nlm.nih.gov/40208688
Image
021
Reposted by Danny Gale
Kidney International @kidneyint.bsky.social · 17/04/2025
Treatment of patients with IgA nephropathy: a call for a new paradigm doi.org/10.1016/j.kint.2025.01.014 #KIReview #OpenAccess #MedSky #NephSky #IgAN #IgAnephropathy
095
Reposted by Danny Gale
Zornitza Stark @zornitza.bsky.social · 24/03/2025
As @ausgenomics.bsky.social comes to an end: what have we learned? 🇦🇺🧬 @naturemedicine.bsky.social 👉 rdcu.be/eeuAN Change is hard! Key for success: working across disciplines; jurisdictions; and all leadership levels🏆 @stephaniebest.bsky.social @iliasgoranitis.bsky.social @andrewmallett8.bsky.social
rdcu.be
Using implementation science to navigate the complexity of integrating genomics into healthcare
Nature Medicine - Australian Genomics led a country-level, longitudinal project to deliver and evaluate the impact of genomics in routine healthcare.
21811
Danny Gale @dannygale.bsky.social · 12/03/2025
Statistician wanted! The UK National Registry of Rare Kidney Diseases (RaDaR) is looking for a statistician to join our team using patient data to unlock improvements in care for people with rare kidney diseases. If you are interested click here shortlink.is/fzNsRD or message me.
shortlink.is
Senior Statistician
Are you an experienced statistician with the expertise to work independently and lead impactful research? Do you want to apply your skills to shape cr
010
Reposted by Danny Gale
Michelle Rheault, MD @rheaultm.bsky.social · 08/03/2025
Prospective Cohort Study in #Alport Syndrome Patients under Standard Therapy - the ATHENA study www.kireports.org/article/S246...
kireports.org
Prospective Cohort Study in Alport Syndrome Patients under Standard Therapy
Patients with Alport syndrome, a common genetic kidney disease, exhibit variable rates of decline in kidney function. Consequently, this global, multicenter, prospective observational study aimed to g...
1278
Reposted by Danny Gale
American Journal of Kidney Diseases @ajkd.bsky.social · 01/03/2025
#NephMadness 2025: Minimal Change Disease Region buff.ly/qk4LG8w Teams: - MCD Diagnosis and Pathogenesis - MCD Relapse Expert: Susan Samuel Writers: Mallory Downie & Robert Myette Execs: Ana Catalina Alvarez-Elías & @nephrosparks.bsky.social
buff.ly
#NephMadness 2025: Minimal Change Disease Region
Submit your picks! | @NephMadness | @nephmadness.bsky.social | NephMadness 2025 Selection Committee Member: Susan Samuel @drsusansamuel Susan Samuel is a Clinician Scientist and Pediatric Nephrolog…
166
Reposted by Danny Gale
ISNkidneycare @theisn.org · 28/02/2025
Globally, 150+ rare kidney diseases affect 60–80 people per 100,000. Many are hereditary, with inherited kidney disease seen in 10% of adults & most children on #KRT. Yet, barriers to diagnosis & treatment persist, especially in LMICs. On #RareDiseaseDay, we call for action! #KidneyHealthMatters
138
Reposted by Danny Gale
grahamabra.bsky.social @grahamabra.bsky.social · 27/02/2025
Somehow missed this excellent VA of the RaDaR study that has changed hearts and minds in IgA Nephropathy, breaking the sound barrier of 1g/day of proteinuria as are standard for high risk of progression
2145
Reposted by Danny Gale
Alport UK @alportuk.bsky.social · 25/02/2025
Exciting progress in Alport research! 🎉 The Alport Research Hub, led by Prof. Rachel Lennon, is uniting experts and patients to improve diagnosis, treatment & care. Watch the video to learn all about The Alport Research Hub @rachellennon.bsky.social @kidneyresearchuk.org
084
Reposted by Danny Gale
Katalin Susztak @ksusztak.bsky.social · 07/02/2025
🎇Our new paper in @ScienceMagazine : Kidney Multiome-Based Genetic Scorecard Reveals Convergent Coding and Regulatory Variants. @Hongbo919Liu science.org/doi/10.1126/...
science.org
Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants
Kidney dysfunction is a major cause of mortality, but its genetic architecture remains elusive. In this study, we conducted a multiancestry genome-wide association study in 2.2 million individuals and...
106623
Reposted by Danny Gale
Michelle Rheault, MD @rheaultm.bsky.social · 14/12/2024
Genotype-First Analysis in an Unselected Health System–Based Population and Phenotypic Severity of COL4A5 Variants. tl;dr The spectrum of kidney disease in those with COL4A5 variants is broad and under diagnosed. journals.lww.com/jasn/abstrac...
journals.lww.com
Genotype-First Analysis in an Unselected Health... : Journal of the American Society of Nephrology
udy, an unselected health system-based cohort with exome sequencing and electronic health records. Patients with COL4A5 variants reported as pathogenic or likely pathogenic in ClinVar, or protein-trun...
12110
Reposted by Danny Gale
Brendon Neuen @brendonneuen.bsky.social · 12/12/2024
The PARASOL initiative started after the DUPLEX trial results were presented by @rheaultm.bsky.social in 2023 On #kidneycompass, Laura Mariani shares how remarkable progress can be possible in a short time when groups work together towards a common goal #FSGS www.hcplive.com/view/kidney-...
hcplive.com
Kidney Compass: PARASOL Background and FSGS Landscape
In part 2 of 4 from this episode, the discussion focuses on the groundbreaking work of the RADAR Registry and the PARASOL Initiative.
0127
Reposted by Danny Gale
imperialtxgroup.bsky.social @imperialtxgroup.bsky.social · 26/11/2024
Congratulations Steph Chong and colleagues at UCL renal on this important work. www.thelancet.com/journals/ebi...
thelancet.com
Composition of the neutralising antibody response predicts risk of BK virus DNAaemia in recipients of kidney transplants
BKV nAb mismatch predicts post-transplant BKV DNAaemia. Specific mismatches in nAb, rather than total seroreactivity, are key indicators of BKV risk post-transplant. This has the potential to risk-str...
092
Reposted by Danny Gale
Emilie Wigdor @emiliewigdor.bsky.social · 20/11/2024
📣 Big news! Our tag-team effort on common variants in rare neurodevelopmental conditions is now out in Nature 📣 Co-first authoring with the brilliant Qinqin Huang🌟—proof that teamwork does make the dream work. 💪 www.nature.com/articles/s41...
media.tenor.com
a couple of cartoon characters standing next to each other with one wearing a purple earring
Alt: a couple of cartoon characters standing next to each other with one wearing a purple earring
1115847